Impact of depression and antidepressant use on clinical outcomes of hepatitis B and C: a population-based study
Background:. Depression is common in patients with chronic viral hepatitis. We evaluated the impact of major depressive disorder (MDD) and antidepressant use on survival among patients with HBV and HCV. Methods:. We used The Health Improvement Network database, the largest medical database in the UK...
Main Authors: | Abdel Aziz Shaheen, Gilaad G. Kaplan, Keith A. Sharkey, B. Cord Lethebe, Mark G. Swain |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health/LWW
2023-03-01
|
Series: | Hepatology Communications |
Online Access: | http://journals.lww.com/10.1097/HC9.0000000000000062 |
Similar Items
-
Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative Review
by: Kiarash Riazi, et al.
Published: (2022-10-01) -
Bipolar depression and treatment with antidepressants.
by: Goodwin, G
Published: (2012) -
Physical Activity and Prevalence of Depression and Antidepressants in the Spanish Population
by: Carmen Galán-Arroyo, et al.
Published: (2022-02-01) -
The Antidepressant Mirtazapine Activates Hepatic Macrophages, Facilitating Pathogen Clearance While Limiting Tissue Damage in Mice
by: Rachelle Paige Davis, et al.
Published: (2020-11-01) -
Suicide, depression, and antidepressants.
by: Cipriani, A, et al.
Published: (2005)